TSHA

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

• Taysha Gene Therapies and Catalent expanded their partnership to support future commercial manufacturing of TSHA-102Aug 3, 2026
• Taysha Gene Therapies completed dosing in the REVEAL pivotal trial and reported longer-term data for TSHA-102 in Rett syndromeJun 22, 2026
• Taysha Gene Therapies reports progress across TSHA-102 pivotal gene therapy program in Rett syndromeJan 6, 2026
• Taysha Gene Therapies presents new supplemental data from Part A of REVEAL Phase 1/2 trials for TSHA-102 in Rett syndrome at 54th CNS Annual MeetingOct 9, 2025
• Taysha Gene Therapies receives FDA Breakthrough Therapy designation and updates positively on TSHA-102 for Rett syndromeOct 2, 2025